United States · FDA National Drug Code directory
TAVABOROLE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-686_01ca8568-cd52-42e0-87b8-2eea35a77364
- Product NDC
- 69097-686
- Form
- SOLUTION
- Composition / generic term
- TAVABOROLE
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210218
- Source listing expiry
- 20261231
Source-listed ingredients
- TAVABOROLE — 43.5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, WITH APPLICATOR in 1 CARTON (69097-686-37) / 10 mL in 1 BOTTLE, WITH APPLICATOR · 69097-686-37
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →